Aristotle Capital Boston’s Axalta AXTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11M Sell
322,430
-63,480
-16% -$1.91M 0.74% 64
2026
Q1
$10.7M Sell
385,910
-60,183
-13% -$1.91M 0.67% 69
2025
Q4
$14.4M Sell
446,093
-45,728
-9% -$1.34M 0.79% 57
2025
Q3
$14.1M Sell
491,821
-7,129
-1% -$215K 0.73% 63
2025
Q2
$14.8M Sell
498,950
-5,099
-1% -$159K 0.75% 56
2025
Q1
$16.7M Sell
504,049
-51,191
-9% -$1.82M 0.84% 46
2024
Q4
$19M Buy
+555,240
New +$20.9M 0.7% 57

Other funds holding AXTA

Aristotle Capital Boston's AXTA Position: Q2 2026 in Review

Aristotle Capital Boston reduced its Axalta (AXTA) stake by 16% in Q2 2026, selling an estimated $1.91M and leaving 322,430 shares worth $11M. The position accounts for 0.74% of the portfolio, ranked #64.

Aristotle Capital Boston first reported a position in AXTA in Q4 2024 and has held it in 7 quarters since. The position peaked at $19M in Q4 2024. 359 funds tracked by Wall St. Rank hold AXTA as of Q2 2026.

  • Aristotle Capital Boston held 322,430 shares of Axalta worth $11M as of Q2 2026.
  • Aristotle Capital Boston sold 63,480 Axalta shares in Q2 2026, an estimated $1.91M.
  • Axalta made up 0.74% of Aristotle Capital Boston's portfolio in Q2 2026, its #64 holding.
  • Aristotle Capital Boston first reported a position in Axalta in Q4 2024 and has held it in 7 quarters since.
  • Aristotle Capital Boston's Axalta position peaked at $19M in Q4 2024.
  • 359 funds tracked by Wall St. Rank held Axalta as of Q2 2026.

Based on Aristotle Capital Boston's 13F filing for Q2 2026, filed 14 Aug 2026.